Phase 3 Study of Iluvien for Diabetic Macular Edema - ONA
Links shared publicly online about this topic.
- 320total visits
Phase 3 Study of Iluvien for Diabetic Macular Edema - ONA
View full resource at oncologynurseadvisor.com
Tags: Edema, Diabetes, Phase 3 Clinical Trial
Most Recently Shared on May 3, 2011 at 3:59 pm By:
Phase 3 Study of Iluvien for Diabetic Macular Edema http://goo.gl/fb/e9mrq
PSivida Announces New Safety And Efficacy Data From Phase 3 Study Of ILUVIEN(R) In Diabetic Macular Edema | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “PSivida Announces New Safety And Efficacy Data From Phase 3 Study Of ILUVIEN(R) In Diabetic Macular Edema | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on May 5, 2011 at 3:41 pm By:
PSivida Announces New Safety And Efficacy Data From Phase 3 Study Of ILUVIEN(R) In Diabetic… http://goo.gl/fb/G8LRl
Phase 3 Study of Iluvien for Diabetic Macular Edema - MPR
empr.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 4:06 pm By:
MPR News: Phase 3 Study of Iluvien for Diabetic Macular Edema: pSivida Corp. announced new data from its Phase 3... http://bit.ly/iisxtm
pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN in Diabetic Macular Edema - Drugs.com MedNews
drugs.com — “May 3, 2011 - pSivida Corp. (NASDAQ PSDV)(ASX PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases,” View full resource at drugs.com
Most Recently Shared on May 3, 2011 at 3:14 pm By:
Drugs and Devices OW OW Health
pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN in Diabetic Macular Edema: WA... http://bit.ly/m4Qvh9 #drug
pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN® in Diabetic Macular Edema | EON: Enhanced Online News
eon.businesswire.com — “pSivida releases additional data from ILUVIEN for diabetic macular edema phase III trial” View full resource at eon.businesswire.com
Most Recently Shared on May 3, 2011 at 2:06 pm By:
Scott Strumello Patient Expert
EON: pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN® in Diabetic Macular Edema http://bit.ly/jows4j
Phase III Study of Lucentis Showed Rapid Vision Improvements Sustained for Two Years in Patients with Diabetic Macular Edema - Drugs.com MedNews
drugs.com — “Mar 10, 2011 - Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY), today announced that two-year results from a pivotal Phase III trial (RISE) sho” View full resource at drugs.com
Most Recently Shared on March 10, 2011 at 2:09 pm By:
Drugs and Devices OW OW Health
Phase III Study of Lucentis Showed Rapid Vision Improvements Sustained for Two Years in Patients with Diab... http://bit.ly/h3SOL6 #drug
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - MPR
empr.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).” View full resource at empr.com
Most Recently Shared on February 4, 2011 at 6:25 pm By:
MPR News: Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME): pSivida Corporation anno... http://bit.ly/gDuoFl
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
drugs.com — “TARRYTOWN, N.Y., Dec. 20, 2010 PRNewswire-FirstCall Regeneron Pharmaceuticals, Inc. (Nasdaq REGN) today announced that it will hold a teleconference and webcast” View full resource at drugs.com
Most Recently Shared on December 20, 2010 at 9:07 pm By:
Drugs and Devices OW OW Health
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase... http://bit.ly/gz434x #drug
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
drugs.com — “In Phase 3 study in CRVO, 56 percent of VEGF Trap-Eye patients gained at least 15 letters of vision compared to 12 percent in control group VEGF Trap-Eye patien” View full resource at drugs.com
Most Recently Shared on December 20, 2010 at 3:01 pm By:
Drugs and Devices OW OW Health
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occ... http://bit.ly/gsAHQw #drug
Phase 3 Study Showed MACUGEN(R) Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema
medicalnewstoday.com — “Results from a Phase 3 study demonstrate MACUGEN® (pegaptanib sodium) significantly improved vision in patients with diabetic macular edema (DME), a complication of diabetes that is a leadi” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2010 at 7:06 pm By:
Phase 3 Study Showed MACUGEN(R) Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema http://mnt.to/3DDS #diabetes
Phase 3 Study Presented At World Ophthalmology Congress Evaluates Investigational Use Of Macugen In Patients With Diabetic Macular Edema
medicalnewstoday.com — “Eyetech Inc. announced that positive results from a Phase 3 study of Macugen® (pegaptanib sodium) in patients with diabetic macular edema (DME) were presented at the World Ophthalmology Congre” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2010 at 3:05 pm By:
Phase 3 Study Presented At World Ophthalmology Congress Evaluates Investigational Use Of Macugen In Patients With Diab... http://mnt.to/3DBd
Anti-VEGF improves vision in diabetic macular edema patients, phase 3 study shows
osnsupersite.com — “BERLIN — A phase 3 study of pegaptanib sodium injection treatment for patients with diabetic macular edema showed significantly improved visua” View full resource at osnsupersite.com
Most Recently Shared on June 6, 2010 at 5:48 pm By:
#Woc2010 - Anti-VEGF improves vision in diabetic macular edema patients, phase 3 study shows: http://ht.ly/1UK5v
Analysis from FAME study finds intravitreal insert effective for treating DME at 30 months
osnsupersite.com — “ATLANTA — A new data analysis from the phase 3 FAME program has found that patients with diabetic macular edema continued to experience significa” View full resource at osnsupersite.com
Most Recently Shared on June 1, 2010 at 3:00 pm By:
Analysis from FAME study finds intravitreal insert effective for treating DME at 30 months: http://ht.ly/1Svnn — #ophthalmology #news
Steroid Implant for Diabetic Macular Edema Nears FDA Approval
retinaeyedoctor.com — “Iluvien, a sustained release drug delivery system, draws closer to FDA approval as Phase 3 clinical trial results show significant improvement in vision.” View full resource at retinaeyedoctor.com
Most Recently Shared on March 17, 2010 at 4:03 pm By:
Randall Wong, MD Surgeon, Ophthalmologist, Physician, and Doctor
Iluvien: New Drug for Diabetic Macular Edema http://goo.gl/fb/M3Ge
pSivida Reports Presentation Of Additional Positive 24-Month Data From Iluvien(R) Phase 3 FAME™ Study For Diabetic Macular Edema At Angiogenesis
medicalnewstoday.com — “pSivida Corp. (NASDAQ:PSDV) (ASX:PVA) (FF:PV3), a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2010 at 4:10 pm By:
pSivida Reports Presentation Of Additional Positive 24-Month Data From Iluvien(R) Phase 3 FAME™ Study For Diabet... http://mnt.to/3ywD
VEGF Trap-Eye Shows Positive Results In Phase II Study In Patients With Diabetic Macular Edema
medicalnewstoday.com — “Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that VEGF Trap-Eye showed positive results in a Phase II study in patients with Diabetic Macular Edema (DME). The p” View full resource at medicalnewstoday.com
Most Recently Shared on February 20, 2010 at 3:08 pm By:
VEGF Trap-Eye Shows Positive Results In Phase II Study In Patients With Diabetic Macular Edema http://mnt.to/3xV5 #diabetes
Advertisement
